Organon & Co. OGN

About Organon & Co. (OGN): stock profile, AI score and financials

Organon & Co. (OGN) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores OGN at 50.3/100 on a composite quality score built from its SEC filings, placing it at rank #1,623 of 2,925 stocks — the bottom half of the AI-ranked universe. OGN scores in the top quartile across earnings quality (92.9), institutional flow (91.4), revenue scale (80.5). Areas of concern include revenue growth (19.8) and profitability (31.0), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), Organon & Co. reports quarterly revenue of $1.6B, net income of $108.0M, an operating margin of 11.8%. OGN trades on the NYSE exchange and files with the SEC under CIK 1821825. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate OGN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Organon & Co. directly from SEC EDGAR.

Financials through the period ended Jun 30, 2026SEC EDGAR: CIK 1821825 →